CN105349641B - 急性心肌梗死相关基因serpinb13及其应用 - Google Patents
急性心肌梗死相关基因serpinb13及其应用 Download PDFInfo
- Publication number
- CN105349641B CN105349641B CN201510727102.8A CN201510727102A CN105349641B CN 105349641 B CN105349641 B CN 105349641B CN 201510727102 A CN201510727102 A CN 201510727102A CN 105349641 B CN105349641 B CN 105349641B
- Authority
- CN
- China
- Prior art keywords
- serpinb13
- myocardial infarction
- acute myocardial
- genes
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Abstract
Description
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510727102.8A CN105349641B (zh) | 2015-10-30 | 2015-10-30 | 急性心肌梗死相关基因serpinb13及其应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510727102.8A CN105349641B (zh) | 2015-10-30 | 2015-10-30 | 急性心肌梗死相关基因serpinb13及其应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105349641A CN105349641A (zh) | 2016-02-24 |
CN105349641B true CN105349641B (zh) | 2018-09-07 |
Family
ID=55325703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510727102.8A Active CN105349641B (zh) | 2015-10-30 | 2015-10-30 | 急性心肌梗死相关基因serpinb13及其应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105349641B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106801101B (zh) * | 2017-02-23 | 2020-12-04 | 吉林大学 | Med6基因作为急性心肌梗死风险预测标记物中的用途 |
CN106929596B (zh) * | 2017-05-08 | 2021-09-10 | 吉林大学 | Cpne3基因作为预测诊疗急性心肌梗死标记物的用途 |
WO2020007270A1 (zh) | 2018-07-03 | 2020-01-09 | 北京泱深生物信息技术有限公司 | 无创诊断心肌梗死的标志物和诊断方法 |
CN108957013B (zh) * | 2018-09-26 | 2021-05-11 | 中国医学科学院北京协和医院 | 与骨关节炎相关的iglon5和serpinb13蛋白及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104611449A (zh) * | 2015-02-13 | 2015-05-13 | 北京泱深生物信息技术有限公司 | Wwp1基因在制备骨肉瘤诊断产品和治疗药物中的应用 |
-
2015
- 2015-10-30 CN CN201510727102.8A patent/CN105349641B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104611449A (zh) * | 2015-02-13 | 2015-05-13 | 北京泱深生物信息技术有限公司 | Wwp1基因在制备骨肉瘤诊断产品和治疗药物中的应用 |
Non-Patent Citations (3)
Title |
---|
Anti-apoptotic Serpins as Therapeutics in Cardiovascular Diseases;Johan Kuiper等;《Cardiovascular & Haematological Disorders-Drug Targets》;20131231;第13卷;第111-122页 * |
Down-regulated expression of SERPIN genes located on chromosome 18q21 in oral squamous cell carcinomas;MASASHI SHIIBA等;《ONCOLOGY REPORTS》;20101231;第24卷;第241-249页 * |
SERPINB13 is a novel RUNX1 target gene;Anita Boyapati等;《Biochem Biophys Res Commun》;20110722;第411卷(第1期);第115-120页 * |
Also Published As
Publication number | Publication date |
---|---|
CN105349641A (zh) | 2016-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105349642B (zh) | 一种急性心肌梗死标志物及其应用 | |
CN105349641B (zh) | 急性心肌梗死相关基因serpinb13及其应用 | |
CN108430336A (zh) | 循环细胞、蛋白质和核酸的体内收集和局部定量以及特征分析 | |
CN105177171B (zh) | Akr1b10在制备急性心肌梗死诊疗制剂中的应用 | |
CN108796069A (zh) | 心肌梗死的诊断标志物-ing1基因 | |
CN107447042A (zh) | 用于诊断活动性结核类疾病的分子标志物及其应用 | |
CN105567862B (zh) | Cdk18在制备诊断冠心病产品中的用途 | |
CN108624680B (zh) | Rae1基因或蛋白作为诊断心肌梗死的生物标志物的应用 | |
CN105734155B (zh) | 软骨母细胞型骨肉瘤致病基因及其应用 | |
KR20120111788A (ko) | 체액 내 세포밖 소포체의 단백질 또는 유전자 분석을 통한 염증성 질환 진단 방법 | |
CN108034707B (zh) | Spag7基因在制备老年痴呆诊断制剂中的应用 | |
CN105256063B (zh) | 肿瘤标志物dmbx1及其应用 | |
CN104984363B (zh) | Zmym1在制备帕金森诊疗试剂中的应用 | |
CN107779503A (zh) | 阿尔茨海默相关的差异表达基因及其应用 | |
CN108796067B (zh) | 血液中maea基因的诊断新功能 | |
CN107937515A (zh) | 一种阿尔茨海默的诊疗基因靶点及其应用 | |
CN108753957A (zh) | 诊断心肌梗死的ivd基因及其应用 | |
CN108796068A (zh) | 用于早期诊断心肌梗死的dock10基因 | |
CN108753956A (zh) | Kdsr基因在制备心肌梗死诊断工具中的应用 | |
CN107937538A (zh) | 胶质瘤诊断标志物circ1:201817088|201817285及应用 | |
CN105420369B (zh) | 一种颅内动脉瘤诊治靶点及其应用 | |
CN109735617A (zh) | 白癜风基因检测标志物及其应用 | |
CN107312836A (zh) | 小分子RNAmiRNA‑146a‑5p在相关疾病风险诊断中的应用 | |
CN106702015A (zh) | Ipcef1在诊治骨肉瘤中的应用 | |
CN107586846A (zh) | 胶质瘤诊断标志物Circ3:129880309|129880559及应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Acute myocardial infarction related gene SERPINB13 and application thereof Effective date of registration: 20181225 Granted publication date: 20180907 Pledgee: Huaxia Bank Beijing branch Wanliu Limited by Share Ltd Pledgor: Beijing Yang Shen biology information technology company limited Registration number: 2018990001252 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20191206 Granted publication date: 20180907 Pledgee: Huaxia Bank Beijing branch Wanliu Limited by Share Ltd Pledgor: Beijing Yang Shen biology information technology company limited Registration number: 2018990001252 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20191212 Address after: Room 2503, Qianshan building, building D2, Qingdao International Innovation Park Phase II, No. 1, Keyuan Weiyi Road, Laoshan District, Qingdao, Shandong Province Patentee after: Qingdao Yangshen biomedical Co., Ltd Address before: 100080 Beijing city Haidian District Shanyuan Street No. 1 cubic court building room 3103 Patentee before: Beijing Yang Shen biology information technology company limited |